Financial Information

This section houses up-to-date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing.

Please note: All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes. Sera Prognostics assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQSERA
Beta0.27
Shares Outstanding31.0M
Average Volume (10 days)85.4K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($1.44)
Sales (TTM)$0.01
Book Value (MRQ)$3.19
Cash Flow (TTM)($1.12)
Cash (MRQ)$2.67

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy4
 
Buy0
 
Hold1
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Gregory C. Critchfield
Director, Chief Executive Officer
62,200
Acquire
Mar 7, 2023
Michael R. Foley
Chief Medical Officer
27,000
Acquire
Mar 6, 2023
Paul Kearney
Chief Data Officer
16,000
Acquire
Mar 6, 2023
Benjamin Jackson
General Counsel
24,700
Acquire
Mar 6, 2023
Robert G. Harrison
Chief Information Officer
28,500
Acquire
Mar 6, 2023

Recent SEC Filings

10-K
Mar 22, 2023
S-8
Mar 22, 2023
Company Events
Mar 22, 2023
Company Events
Mar 10, 2023
Insider Buy/Sell
Mar 7, 2023

Email Alerts

Sign up for our investor relations email list here.